Results 41 to 50 of about 24,793 (277)
F1000Research, 2019 Late-onset hypogonadism (LOH) is the term used to describe the decline in serum testosterone levels associated with increasing age in men above 40 years.
Tharu Tharakan +3 more
doaj +1 more source
Testosterone Replacement, Muscle Strength, and Physical Function [PDF]
The World Journal of Men's Health, 2018 Muscle strength and physical function decrease in older men, as do testosterone levels. Nonetheless, the effects of testosterone replacement therapy on muscle strength and physical function remain inconclusive and equivocal.
You-Seon Nam +3 more
doaj +1 more source
Testosterone replacement therapy in the era of telemedicine [PDF]
International Journal of Impotence Research, 2021 The events of the 2019 SARS-CoV2 virus pandemic have all but ensured that telemedicine will remain an important aspect of patient care delivery. As health technologies evolve, so must physician practices. Currently, there is limited data on the management of testosterone replacement therapy (TRT) in the era of telemedicine.
Justin M. Dubin +2 more
openaire +2 more sources
A Validated Age-Related Normative Model for Male Total Testosterone Shows Increasing Variance but No Decline after Age 40 Years [PDF]
, 2014 The diagnosis of hypogonadism in human males includes identification of low serum testosterone levels, and hence there is an underlying assumption that normal ranges of testosterone for the healthy population are known for all ages.
Wallace, W Hamish B +25 more
core +1 more source
F1000Research, 2019 Male hypogonadism is a clinical syndrome characterized by low testosterone and symptoms of androgen deficiency. Prostate cancer remains a significant health burden and cause of male mortality worldwide.
Saiful Miah +7 more
doaj +1 more source
Central serous chorioretinopathy secondary to intramuscular testosterone therapy
Endocrinology, Diabetes & Metabolism Case Reports, 2023 A patient treated with intramuscular testosterone replacement therapy for primary hypogonadism developed blurred vision shortly after receiving his testosterone injection.
M Lockhart +6 more
doaj +1 more source
Testosterone replacement therapy and voiding dysfunction [PDF]
Translational Andrology and Urology, 2016 Testosterone replacement therapy (TRT) represents an increasing popular treatment option for men with late-onset hypogonadism (LOH). Because of unsubstantiated beliefs of testosterone's effect on the prostate, the FDA has recently placed a warning on testosterone products, stating that TRT may worsen benign prostatic hyperplasia (BPH).
Baas, Wesley, Köhler, Tobias S.
openaire +2 more sources
Impact of testosterone levels and testosterone replacement ther-apy on men’s health
Journal of Medical Science, 2023 Various studies have shown that testosterone levels heavily impact many areas of a man’s health. Low serum testosterone (and, by analogy, late onset hypogonadism) may be responsible for such conditions as type 2 diabetes, obesity in abdominal area ...
Zuzanna Karbowska +5 more
doaj +1 more source
Testosterone Replacement Therapy: Long-Term Safety and Efficacy [PDF]
The World Journal of Men's Health, 2017 Recent position statements and guidelines have raised the distinction between a true and false, age-related hypogonadism (HG) or late-onset hypogonadism (LOH).
Giovanni Corona +2 more
doaj +1 more source
Testosterone treatment to mimic hormone physiology in androgen replacement therapy. A view on testosterone gel and other preparations available [PDF]
, 2007 There is still considerable controversy concerning the issue of testosterone replacement therapy. This is because testosterone replacement therapy is not a 'risk-free' treatment and a randomized controlled trial to evaluate safety of prolonged ...
LENZI, Andrea +9 more
core +1 more source